SCHEMBL14036719

SCHEMBL14036719

CCC(C)(C)NC(=O)Cc1ccc(Cl)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 1.00
HPGD P15428 1/20 0.76
KDM4E B2RXH2 1/20 0.71
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
ALDH1A1 P00352 2/20 0.54
MAPT P10636 1/20 0.52
CNR2 P34972 2/20 0.50
LMNA P02545 2/20 0.50
EGFR P00533 2/20 0.49
ERBB2 P04626 2/20 0.49
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
SHMT1 P34896 1/20 0.47
SHMT2 P34897 1/20 0.47
POLB P06746 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8240475 0.84 L3MBTL1 (0.73) L3MBTL1HPGDKDM4EMEN1KMT2A
SCHEMBL10982724 0.83 HPGD (0.75) L3MBTL1HPGDKDM4EMEN1KMT2A
SCHEMBL5964186 0.81 L3MBTL1 (0.68) L3MBTL1HPGDKDM4EMEN1KMT2A
SCHEMBL8233804 0.80 L3MBTL1 (0.67) L3MBTL1HPGDKDM4EMEN1KMT2A
SCHEMBL13702382 0.78 L3MBTL1 (0.64) L3MBTL1HPGDKDM4EKMT2AALDH1A1
SCHEMBL7213632 0.77 L3MBTL1 (0.62) L3MBTL1HPGDKDM4EMEN1KMT2A
SCHEMBL25781021 0.76 L3MBTL1 (0.61) L3MBTL1KDM4EMEN1KMT2ANPC1
SCHEMBL4388479 0.75 ALDH1A1 (0.65) L3MBTL1MEN1KMT2ANPC1RAB9A
SCHEMBL7213629 0.75 L3MBTL1 (0.60) L3MBTL1HPGDMEN1KMT2ANPC1
SCHEMBL6244680 0.74 POLB (0.67) L3MBTL1MEN1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287347-A1 Novel Lipopeptides as Antibacterial Agents CUBIST PHARMACEUTICALS, INC. 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287347-A1 Novel Lipopeptides as Antibacterial Agents CLPTM1, NGLY1, VIP L3MBTL1 2417/4885HPGD 1145/4885KDM4E 4432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.